Mycoses Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • Published on

  • View

  • Download


Mycoses are fungal skin infections caused by fungi and are primarily caused by three groups of fungi: dermatophytes, yeasts and molds. Dermatophytes cause fungal infections on head and feet, for instance, trichophyton and microsporum. Yeasts cause infections at the genital area, mouth area and esophagus.


<ul><li><p>Transparency Market Research</p><p>Mycoses Market - Global IndustryAnalysis, Size, Share, Growth, Trends and</p><p>Forecast 2020</p><p>Single User License:USD 4315.5</p><p> Flat 10% Discount!! Free Customization as per your requirement You will get Custom Report at Syndicated Report price Report will be delivered with in 15-20 working days</p><p>Transparency Market Research State Tower,</p><p>90, State Street, Suite 700.Albany, NY 12207</p><p>United</p><p></p><p>Request Sample</p><p>Buy Now</p></li><li><p>Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Mycoses Market".This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions andworldwide business sector industry structure.</p><p>Mycoses are fungal skin infections caused by fungi and are primarily caused by three groups of fungi: dermatophytes, yeasts andmolds. Dermatophytes cause fungal infections on head and feet, for instance, trichophyton and microsporum. Yeasts cause infectionsat the genital area, mouth area and esophagus. Example of yeast fungi includes candida and pityrosporum. Molds are responsible forinfection in internal organs that results in systemic mycoses, for example, aspergillus. Systemic mycoses lead to the spread of fungivia bloodstream to other organs, causing multiple organ failure. Various symptoms associated with mycoses are as follows:</p><p> Itchy and eczematous rash Itching Lumpy and thickened skin Loss of appetite and weight loss Fever Red skin patches Enlarged liver and spleen Anemia</p><p>Request a Brochure:;rep_id=3112</p><p>Mycoses are caused due to weakened immune systems, i.e., immunocompromised state that includes patients with HIV/AIDS andpatients being treated with corticosteroids for a prolonged period. Other causes include poorly controlled diabetes, being overweight,and any sort of contact with contaminated items such as clothes, towel, etc. Tests used to diagnose mycoses include a general physicalexamination of the body, complete blood count, skin biopsy, flow cytometry and immunophenotyping.</p><p>Based on treatment, the mycoses market can be segmented as follows:</p><p> Photodynamic therapy: The therapy uses laser light and a drug to destroy the fungal cancer cells Radiation therapy: The therapy uses high-energy X-rays or radiation to prevent the fungal cells from spreading Chemotherapy: Chemotherapy stops the growth of fungal cells with the aid of various drugs, either by preventing the cells</p><p>from dividing or by killing the cells</p><p>REPORT DESCRIPTION</p></li><li><p> Targeted therapy: The therapy identifies the affected cells without harming normal cells Drug medication: Antifungal medications such as amphotericin B, fluconazole, caspofungin, and itraconazole are used for the</p><p>treatment of mycoses</p><p>Based on geography, the mycoses market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest ofthe World (RoW). Out of these regions, North America holds a leading position in the mycoses market followed by Europe. Accordingto National Institutes of Health, mycoses affect approximately 200,000 people in the U.S. every year. The major factors which aredriving the growth of the market in these regions are increasing prevalence of AIDS/HIV across the North American region, leading toweakened immune systems of individuals and constantly growing awareness about mycoses. Asia Pacific is also expected to be one ofthe promising markets for the growth of mycoses market due to faster developing rate of Asia Pacific countries. </p><p>The advantageous factors which would accelerate the growth of the market in Asia Pacific are presence of large population base incountries such as China, Japan, and India, prevalence of numerous diabetes patients and, populations changing lifestyle andenvironmental conditions. Furthermore, various tax benefits and favorable reimbursement policies in developing nations are mostlikely to augment the growth of mycoses market. </p><p>Various pharmaceutical companies are coming up with novel therapeutic treatments for mycoses. Some of the top players operating inmycoses market for mycoses therapeutic development are Bayer AG, Dr. Reddy\'s Laboratories Limited, Helix BioMedix, Inc., Merck&amp; Co., Inc., Pfizer, Inc., Nuvo Research, Inc., Moberg Derma AB, Novabiotics Ltd, Pacgen Biopharmaceuticals Corporation,Quinnova Pharmaceuticals, Inc., Xel Pharmaceuticals, Inc. and others. </p><p>Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services.The companys exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands ofdecision makers. TMRs experienced team of analysts, researchers, and consultants use proprietary data sources and various tools andtechniques to gather and analyze information. </p><p>TMRs data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends andinformation. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary andsecondary research techniques to develop distinctive data sets and research material for business reports.</p><p>About Us</p></li><li><p>Transparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: Website:</p><p>Contact</p></li></ul>


View more >